F. W. Bert and Mae Dean Wheeler Foundation establishes Nurse Leadership Academy at MD Anderson with $9 million gift
Grant and Award Announcement
Updates every hour. Last Updated: 8-May-2025 17:09 ET (8-May-2025 21:09 GMT/UTC)
The University of Texas MD Anderson Cancer Center today announced a $9 million gift from the F. W. Bert and Mae Dean Wheeler Foundation to establish the F. W. Bert and Mae Dean Wheeler Nurse Leadership Academy. The Wheeler Foundation’s gift supports MD Anderson’s innovative efforts to cultivate the next generation of oncology nurse leaders as part of the Meyers Institute for Oncology Nursing. The Wheeler Nurse Leadership Academy will focus on providing the coaching and mentoring infrastructure to ensure nurses are equipped with the unique skills to position them as successful leaders.
Gliomas are types of cancers that arise in the brain and are extraordinarily difficult to treat. They are the leading cause of brain tumour-related deaths in both children and adults. Two pioneering scientists are awarded The Brain Prize 2025 for their discoveries that open up an entirely new way of thinking about and understanding these lethal diseases, and the potential strategies to treat them.
The University of Oklahoma Health Sciences has achieved its highest ranking ever in National Institutes of Health funding awarded for research. NIH funding increased to $75.2 million in the previous federal fiscal year, improving the campus’s ranking to 102 out of 2,838 institutions and other entities that receive NIH funding.
While the human papillomavirus (HPV) is most associated with cervical cancer risk and women, a new survey commissioned by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) shows that the majority of people are unaware that the virus is actually more common among men than women and is associated with rising rates of other cancers that directly impact men.
Researchers at University of Arizona Cancer Center used a double-pronged approach to reduce tumor growth in tissue samples of prostate cancer.